From 62acf070ac3070b5210475b4fe768513616c8edc Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Thu, 21 Mar 2024 14:59:12 +0100 Subject: [PATCH] [logseq-plugin-git:commit] 2024-03-21T13:59:11.472Z --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index e0277aa0..52f11dd4 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -1,7 +1,7 @@ # [[WHO]] visit - - # REALISE study registration - - ## The design of our REALISE study + - ## The design of our REALISE study is published - #+BEGIN_VERSE At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness). The details of the trial have been published in clinicaltrials.gov and the Pan African Clinical Trial Registry, and are now ready to be delivered to the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries were it will be carried out.